Abstract

JAK1/2 Inhibitor Ruxolitinib Controls a Case of Chilblain Lupus Erythematosus

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Atopic dermatitis: Therapeutic concepts evolving from new pathophysiologic insights
Thomas Jung ... Georg Stingl
Journal of Allergy and Clinical Immunology | VOL. 122
Thomas Jung, et. al.Thomas Jung ... Georg Stingl
06 Nov 2008
Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology
Luz Fonacier ... Donald Y.M Leung
Journal of Allergy and Clinical Immunology | VOL. 115
Luz Fonacier, et. al.Luz Fonacier ... Donald Y.M Leung
01 Jun 2005
Molecular Heterogeneity of Blistering Disorders: The Paradigm of Epidermolysis Bullosa
Leena Bruckner-Tuderman ... Cristina Has
The Journal of investigative dermatology | VOL. 132
Leena Bruckner-Tuderman, et. al.Leena Bruckner-Tuderman ... Cristina Has
01 Nov 2012
Efficacy of Combined Peroxisome Proliferator-Activated Receptor-α Ligand and Glucocorticoid Therapy in a Murine Model of Atopic Dermatitis
Yutaka Hatano ... Sakuhei Fujiwara
The Journal of investigative dermatology | VOL. 131
Yutaka Hatano, et. al.Yutaka Hatano ... Sakuhei Fujiwara
01 Sep 2011
View more papers

More From: The Journal of investigative dermatology

Paper Title
Journal
Date
Author
Editorial Board
-
The Journal of investigative dermatology | VOL. 144
--
01 Jul 2024
Table of Contents
-
The Journal of investigative dermatology | VOL. 144
--
01 Jul 2024
Subscription Information
-
The Journal of investigative dermatology | VOL. 144
--
01 Jul 2024
Clinical Snippets
-
The Journal of investigative dermatology | VOL. 144
--
01 Jul 2024
View more papers